Creating new environment to improve treatment for limbal stem cell deficiency

You've probably seen the late night ads and the onslaught of cosmetic marketing - hyaluronic acid or hyaluronan, touted as the "fountain of youth," the best moisturizer or skin plumper on the market. It turns out, this naturally occurring molecule, with high concentrations in the eyes, is necessary for creating stem cells in the limbus, the border of the cornea and whites of the eye (sclera). Limbal stem cells regenerate the cornea after serious corneal injury. Patients who lack these cells and their environment develop a condition called limbal stem cell deficiency which causes opaque corneas.

"Our hope is to use the knowledge of hyaluronan in creating stem cells to improve the treatment of patients with limbal stem cell deficiency," said assistant professor of optometry Vivien Coulson-Thomas whose research is supported by a $1.9M grant from the National Eye Institute.

She previously discovered that hyaluronan in the eyes is present exclusively in the corneal limbus.

"This grant is to look at how the hyaluronan creates limbal stem cells and we will also look at whether we can take a cell, put it on a hyaluronan layer, or substrate, and create new stem cells in the lab," said Coulson-Thomas.

Stem cells, the body's version of cells on reserve, exist in a nonspecific state until called upon to transform into the kind of cell that can produce new body tissue for either maintenance or to repair an injury. Every cell needs the proper environment to grow, and Coulson-Thomas is exploring what environment corneal stem cells need to do their job and then recreate that environment in patients where it has been damaged.

"The environment, called the extracellular matrix, can make a stem cell turn into something else. If you change the environment, you change the cell," said Coulson-Thomson, who has studied the extracellular matrix for 20 years, one of the few researcher experts in this understudied field. The cell itself influences what is in the extracellular matrix and one of those things is hyaluronan.

Substantial evidence shows that the cornea contains a limbal stem cell niche containing limbal stem cells, which are vital for reconstituting the corneal epithelium after injury. Injury to the cornea leading to substantial damage of the niche may decrease the overall number of limbal stem cells, reducing the ability of these cells to resurface the corneal epithelium. In severe cases this can lead to limbal stem cell deficiency, a serious medical condition.

Even if a patient has a few remaining limbal stem cells, its extracellular matrix is filled with scar tissue, so the cells will not remain stem cells. Coulson-Thomas will explore increasing stem cells by determining the ideal substrate layer for their growth in a petri dish.

"If you put the stem cells on plastic dishes with environments completely foreign to the cells, not all the cells will stay stem cells, they're going to become other kinds of cells, and then who knows what kind of cells will eventually be put into a recipient," said Coulson-Thomas. Her method to control the outcome includes expanding substrates with hyaluronan and then measuring the percentage of cells that remain stem cells.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Small brain-penetrating molecule offers hope for treating aggressive brain tumors